New Animal Drug Applications; Beta-Aminopropionitrile Fumarate; n-Butyl Chloride; Cupric Glycinate Injection; Dichlorophene and Toluene; Orgotein for Injection; Tetracycline Tablets
other · Food and Drug Administration · Rule · Published 2021-02-23 · Effective 2021-02-23 · 86 FR 10818
Document
Document number
2021-03251
Federal Register citation
86 FR 10818
CFR reference
21 CFR 510
Type
Rule
Action
Final rule, technical amendment.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2021-02-23
Effective date
2021-02-23
HHS docket
Docket No. FDA-2019-N-5405
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of seven new animal drug applications (NADAs) for lack of compliance with the reporting requirements in an FDA regulation.